Sequelae and survivorship in patients treated with (131)I-MIBG therapy.

Sequelae and survivorship in patients treated with (131)I-MIBG therapy.

Show other versions (1)

BACKGROUND: (131)I-meta-iodobenzylguanidine ((131)I-MIBG) has been in therapeutic use since 1980s. Newer treatment modalities are emerging for neuroendocrine tumours (NETs) and chromaffin cell tumours (CCTs), but many of these do not yet have adequate long-term follow-up to determine their longer te...

Full description

Bibliographic Details
Main Authors:	Sze, W, Grossman, AB, Goddard, I, Amendra, D, Shieh, S, Plowman, P, Drake, WM, Akker, SA, Druce, MR
Format:	Journal article
Language:	English
Published:	2013

Similar Items

Sequelae and survivorship in patients treated with 131 I-MIBG therapy
by: Sze, W, et al.
Published: (2013)

Morbidity in patients on long-term steroid replacement therapy.
by: Druce, MR, et al.
Published: (2010)

Treatment of metastatic pheochromocytoma and paraganglioma with I-131-meta-iodobenzylguanidine (MIBG)
by: Kaltsas, G, et al.
Published: (2003)

Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].
by: Mukherjee, J, et al.
Published: (2001)

Familial paraganglioma: a novel presentation of a case and response to therapy with radiolabelled MIBG.
by: Lawrence, J, et al.
Published: (2004)

Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors (vol 161, pg 131, 2009)
by: Procopiou, M, et al.
Published: (2009)

Intra-abdominal fibrosis in a recent cohort of patients with neuroendocrine ('carcinoid') tumours of the small bowel.
by: Druce, MR, et al.
Published: (2010)

Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors (European Journal of Endocrinology 161, 1, (131-140))
by: Procopiou, M, et al.
Published: (2009)

Intra-abdominal fibrosis in a modern cohort of patients with mid-gut carcinoid tumours - a cross-sectional survey from one centre
by: Druce, MR, et al.
Published: (2009)

Intra-Abdominal Fibrosis in a Modern Cohort of Patients with Mid-Gut Carcinoid Tumors - A Cross-Sectional Survey from One Centre
by: Druce, MR, et al.
Published: (2009)

Peptide Receptor Radionuclide Treatment and (131)I-MIBG in the management of patients with metastatic/progressive phaeochromocytomas and paragangliomas
by: Nastos, K, et al.
Published: (2017)

I131-MIBG treatment revisited: How important is scheduling when combined with external beam irradiation?
by: Corroyer-Dulmont, A, et al.
Published: (2016)

The value of radiolabelled MIBG and octreotide in the diagnosis and management of neuroendocrine tumours.
by: Kaltsas, G, et al.
Published: (2001)

The management of differentiated thyroid cancer using 123I for imaging to assess the need for 131I therapy.
by: Ali, N, et al.
Published: (2006)

Are serotonin metabolite levels related to bone mineral density in patients with neuroendocrine tumours?
by: Gupta, P, et al.
Published: (2014)

MIBG scans for phaeochromocytoma: time to abandon the technique?
by: Grossman, A, et al.
Published: (2009)

Are serotonin metabolite levels related to bone mineral density in patients with neuroendocrine tumours?
by: Sen Gupta, P, et al.
Published: (2014)

I-123 imaging for the prediction of I-131 therapy for recurrent differentiated thyroid cancer, RDTC, when I-131 tracer is negative but raised thyroglobulin, Tg
by: Britton, K, et al.
Published: (1999)

Targeted radionuclide therapy for neuroendocrine tumours: principles and application.
by: Druce, MR, et al.
Published: (2010)

Improved outcome of 131I-mIBG treatment through combination with external beam radiotherapy in the SK-N-SH mouse model of neuroblastoma
by: Corroyer-Dulmont, A, et al.
Published: (2017)

Single photon emission computed tomography (SPECT)/computed tomography using Iodine-123 in patients with differentiated thyroid cancer: additional value over whole body planar imaging and SPECT.
by: Barwick, T, et al.
Published: (2010)

Does sociality increase survivorship in bats
by: Neo, Wivian Hui Yuan
Published: (2023)

Cancer survivorship: the impact on primary care.
by: Watson, E, et al.
Published: (2011)

The effect of exogenous glucocorticoids on plasma catecholamines and metanephrines in patients without phaeochromocytomas.
by: Druce, MR, et al.
Published: (2011)

The Effect of Exogenous Glucocorticoids on Plasma Catecholamines and Metanephrines in Patients Without Phaeochromocytomas
by: Druce, MR, et al.
Published: (2012)

Multimodality palliative treatment of (111)In-pentetreotide negative/(123)I-MIBG positive metastatic carcinoid - a case report.
by: Dworakowska, D, et al.
Published: (2008)

123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation.
by: Bhatia, K, et al.
Published: (2008)

Neurological sequelae of cerebral malaria.
by: Dollow, S
Published: (1996)

Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA pentetreotide.
by: Kaltsas, G, et al.
Published: (1998)

Fibrosis and carcinoid syndrome: from causation to future therapy.
by: Druce, M, et al.
Published: (2009)

Routine preoperative (123)I-MIBG scintigraphy for patients with phaeochromocytoma is not necessary.
by: Mihai, R, et al.
Published: (2008)

The education experiences of eight American adolescents in cancer survivorship
by: Erickson, J
Published: (2016)

Assessment of serum-free cortisol levels in patients with adrenocortical carcinoma treated with mitotane: a pilot study.
by: Alexandraki, K, et al.
Published: (2010)

Meningococcal disease: clinical presentation and sequelae.
by: Pace, D, et al.
Published: (2012)

Neurological sequelae of cerebral malaria in children.
by: Brewster, DR, et al.
Published: (1990)

Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors.
by: Procopiou, M, et al.
Published: (2009)

Simultaneous ⁹⁹m̳Tc-MDP/¹²³I-MIBG imaging of neuroblastoma using SPECT-CT
by: Pérez-Gutiérrez, José P. (José Pablo Andrés)
Published: (2013)

Presumption of Survivorship Act 1950 (Act 205) (Revised 1978)
by: Ali Mohamed, Ashgar Ali
Published: (2010)

Defining cancer survivorship: a more transparent approach is needed
by: Khan, N, et al.
Published: (2011)

Defining cancer survivorship: a more transparent approach is needed.
by: Khan, N, et al.
Published: (2012)